GlaxoSmithKline Pakistan Limited (PSX:GLAXO)
Pakistan · Delayed Price · Currency is PKR 393.49
+13.26 (3.49%)
At close: Apr 17, 2026
GlaxoSmithKline Pakistan Revenue
In the year 2025, GlaxoSmithKline Pakistan had annual revenue of 65.90B PKR with 7.70% growth. GlaxoSmithKline Pakistan had revenue of 21.41B in the quarter ending December 31, 2025, with 21.76% growth.
Revenue
65.90B
Revenue Growth
+7.70%
P/S Ratio
1.90
Revenue / Employee
38.77M
Employees
1,606
Market Cap
125.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 65.90B | 4.71B | 7.70% |
| Dec 31, 2024 | 61.19B | 11.53B | 23.21% |
| Dec 31, 2023 | 49.66B | 7.82B | 18.69% |
| Dec 31, 2022 | 41.84B | 5.18B | 14.13% |
| Dec 31, 2021 | 36.66B | 1.57B | 4.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories (Pakistan) | 75.40B |
| The Searle Company | 33.26B |
| AGP Limited | 28.89B |
| Highnoon Laboratories | 27.71B |
| Ferozsons Laboratories | 22.22B |
| Citi Pharma | 14.10B |
| Macter International | 11.58B |
| Otsuka Pakistan | 4.26B |